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ABSTRACT
Objectives: Following a 3.7-fold increase in the rate of
cataract surgery in the UK between 1989 and 2004,
concern has been raised as to whether this has been
accompanied by an excessive decline in the threshold
such that some operations are inappropriate. The
objective was to measure the impact of surgery on a
representative sample of patients so as to determine
whether or not overutilisation of surgery is occurring.
Design: Prospective cohort assessed before and
3 months after surgery.
Setting: Ten providers (four NHS hospitals, three NHS
treatment centres, three independent sector treatment
centres) from across England.
Participants: 861 patients undergoing first eye (569) or
second eye (292) cataract surgery provided preoperative
data of whom 745 (87%) completed postoperative
questionnaires.
Main outcome measures: Patient-reported visual
function (VF-14); general health status and quality of life
(EQ5D); postoperative complications; overall view of the
operation and its impact.
Results: Overall, visual function improved (mean VF-14
score increased from 83.2 (SD 17.3) to 93.7 (SD 13.2)).
Self-reported general health status deteriorated (20.3%
fair or poor before surgery compared with 25% after-
wards) which was reflected in the mean EQ5D score
(0.82 vs 0.79; p = 0.003). At least one complication was
reported by 66 (8.9%) patients, though this probably
overestimated the true incidence. If the appropriateness
of surgery is based on an increase in VF-14 score of 5.5
(that corresponds to patients’ reporting being ‘‘a little
better’’), 30% of operations would be deemed inap-
propriate. If an increase of 12.2 (patients’ reports of being
‘‘much better’’) is adopted, the proportion inappropriate is
49%. Using a different approach to determining a
minimally important difference, the proportion inappropri-
ate would be closer to 20%. Although visual function (VF-
14) scores were unchanged or deteriorated in 25% of
patients, 93.1% rated the results of the operation as
‘‘good,’’ ‘‘very good’’ or ‘‘excellent,’’ and 93.5% felt their
eye problem was ‘‘better.’’ This partly reflects inadequa-
cies in the validity of the VF-14.
Conclusions: Improvement in the provision of cataract
surgery has been accompanied by a reduction in the
visual function threshold. However, methodological
difficulties in measuring the impact of cataract surgery on
visual function and quality of life mean it is impossible to
determine whether or not overutilisation of cataract
surgery is occurring.
The rate of surgery for cataract has increased
dramatically in many countries over the last
20 years.1 In the UK it rose from 173 to 637 per
100 000 between 1989 and 2004,2 excluding
privately funded surgery. During the 1990s, the
increase was due to the advent of day surgery, the
introduction of phacoemulsification and the shift
from general to local anaesthesia. Despite the rate
having increased 2.5-fold in England by 2000,
patients still faced an average wait for surgery of
7 months. In response, the Department of Health
published Action on Cataracts, which led to a
further 63% increase in the surgical rate.3 4 And in
2003, the government funded the introduction of
additional providers, in the form of Independent
Sector Treatment Centres, to boost the rate still
further.5
Concern about possible overuse of cataract
surgery was first expressed in Canada in 2002.
Wright and colleagues reported that for 27% of
patients treated in Vancouver in 1999–2000, their
self-reported visual function was the same or worse
following surgery.6 In 2004 in the UK, the Royal
College of Ophthalmologists re-emphasised the
need to ensure that surgery was only performed
when a patient’s lifestyle was restricted by their
symptoms7 (though their guidelines made an
exception for patients with ocular comorbidity).
There is no doubt that an increasing rate of
surgery in many countries has been accompanied
by a lowering of the threshold of visual dysfunc-
tion, as determined by patients’ reports of any
difficulties they are encountering because of their
vision. Using the most commonly employed
patient-reported measure, the VF-148 in which a
score of 100 represents no difficulties, eight studies
in the 1990s in USA, Spain, Canada, Denmark, UK
and Sweden found the mean preoperative score
was 62.9–76.0.9–14 In contrast, three studies in
Canada, Australia and Scotland carried out since
2000 report the mean score has risen to 73.0–
84.4.6 12 15
A suggestion that increased rates of surgery in
England might have been accompanied by an
excessive reduction in the threshold, leading to
unnecessary surgery, has recently been made,2
prompting the suggestion that observational stu-
dies of patients’ outcomes are needed.16 To
investigate the appropriateness of cataract surgery,
we examined the impact of surgery on a represen-
tative cohort of patients.
METHODS
Ten providers (four NHS hospitals, three NHS
treatment centres, three independent sector treat-
ment centres) from a wide geographical area of
England agreed to participate. This paper is based
on an opportunistc analysis of data collected in a
project to test the feasibility of routine collection
of data from NHS patients before and after
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surgery.17 Ethics approval was obtained from an MREC. During
the recruitment period in 2006, 1485 patients underwent
cataract removal, but 253 (17.0%) were judged to be incapable
of completing a written questionnaire in English because of
cognitive impairment, poor sight, literacy or language-compre-
hension problems. Of the 1232 eligible patients, 1025 (83.2%)
were invited by local staff to participate, of whom 860 (83.9%)
agreed.
Patients completed a preoperative questionnaire either in a
preoperative assessment clinic or on admission for surgery. The
following information was collected: age, sex and postcode (to
determine an Index of Multiple Deprivation. a proxy measure of
socio-economic status where higher scores represent greater
deprivation); duration of symptoms; history of previous similar
surgery; general health status; comorbidities (21 categories);18
the VF-14; and the index part of the EQ-5D, a generic measure
in which higher scores represent better health-related quality of
life.19
Postoperative questionnaires were mailed 3 months after
surgery to patients’ homes from the Royal College of
Surgeons of England. Non-responders were sent a reminder
letter and replacement questionnaire 5 weeks after the original
mailing. Of the 860 patients recruited, 745 (87%) completed
postoperative questionnaires. The questionnaires contained: the
EQ-5D and the VF-14; a question relating to four generic
postoperative complications (allergy or reaction to drug, and
urinary, bleeding or wound problems);20 a question on the
overall result of the operation; and a question on its overall
impact on the patient’s eye problem.
Preoperative data are shown for all 860 recruited patients.
Prepost comparisons are limited to the 745 postoperative
respondents. The association between general health status
and EQ5D was tested by regression with general health status
treated as a continuous variable. Oldham’s method was used to
show the association between change and initial value of the
VF-14.21 Multivariable regression models (linear and logistic)
were built to identify which factors influenced postoperative
VF-14 and EQ-5D scores and the complication rate. Variables
were retained in the models if p,0.1.
RESULTS
Characteristics of patients
The mean age of the patients was 74.2 (SD 9.8) years, and
57.5% were women. The median IMD score (socio-economic
status) was 15.6 (interquartile range (IQR) 10.1 to 24.4).
The median time that patients had suffered from visual
symptoms was 2 years (IQR 1–4 years). About a third (34%)
were undergoing second-eye cataract surgery. The median
number of systemic co-morbidities reported (from a list of 21)
was 1.5 (IQR 1–3).
About 80% of patients described their general health as at
least good: good 44.6%; very good 29.1%; excellent 6.0%. Of the
rest, 18.3% reported fair and 2.0% poor. This distribution was
reflected in their EQ5D scores: mean 0.81 (SD 0.23). There was
a positive association between self-rated general health and EQ-
5D (p,0.0001)—as general health increases towards ‘‘excellent’’
the mean EQ-5D score increases.
The mean preoperative VF-14 score was 82.7 (SD 17.3) (83.2
for those who subsequently completed a postoperative ques-
tionnaire). The distribution (fig 1) reveals a large proportion
reporting little or no dysfunction. The 292 (34%) patients
undergoing second-eye surgery were more likely to have a score
of 90 or more than those having surgery for the first time (56%
vs 44%).
Outcome
Three months after surgery, the mean VF-14 score was 93.7 (SD
13.2), representing a mean improvement of 10.5 (SD 16.5). The
extent of improvement was related to the degree of preoperative
visual dysfunction: the worse a patient’s visual function was
before surgery, the greater was the extent of their improvement.
While this was partly due to regression to the mean, a
statistically significant association remains after this is taken
into account (fig 2). Positive scores on the vertical axis refer to
Table 1 Association between ‘‘How would you describe
the results of your operation?’’ and VF-14 change scores
Response n (%) VF-14 change score mean (SD)
Excellent 338 (45.9) 12.2 (15.7)
Very good 218 (29.6) 10.9 (13.9)
Good 130 (17.6) 10.7 (17.2)
Fair 32 (4.3) 0.4 (17.3)
Poor 19 (2.6) –12.8 (29.0)
Overall 737 (100.0) 10.4 (16.6)
Figure 1 Distribution of preoperative VF-14 scores.
Figure 2 Extent of change in VF-14 score by mean of the pre- and
postoperative scores. The line represents the relationship allowing for
regression to the mean.
Clinical science
14 Br J Ophthalmol 2009;93:13–17. doi:10.1136/bjo.2007.136150
 on 30 January 2009 bjo.bmj.comDownloaded from 
improvement. A quarter of the patients reported no change or a
worsening of their visual function.
There was some deterioration in patients’ general health:
25.0% reported their general health as only fair or poor
(compared with 20.3% before surgery), and the mean EQ-5D
score declined from 0.82 to 0.79 (p = 0.003). Postoperative
general health complications were reported by 66 (8.9%)
patients: allergy/reaction to drug 3.0%; urinary problem 1.7%;
bleeding 3.0%; and wound problem 2.7%. The decline in the EQ-
5D score was not associated with the occurrence of complica-
tions: the score declined in 77% of those with no complication
and in 78% of those reporting a complication.
Most patients (93.1%) described the results of their operation
as good or better: 17.6% good; 29.6% very good; 45.9%
excellent. The mean change in VF-14 scores was greater in
patients who were more satisfied with the results of their
operation (table 1).
Overall, most patients felt their visual problem was much
better (82.0%) or a little better (11.5%) following surgery. Only
3.4% felt no benefit or worse. Again, these views were reflected
in the changes in VF-14 scores (table 2).
Determinants of outcome
Multivariate analyses revealed three factors influenced the
postoperative VF-14 score: preoperative VF-14 score, age and
general health status. These three variables explained 20% of the
variation between patients in postoperative VF-14 score.
Determinants of the postoperative EQ-5D score were:
preoperative EQ-5D, age, general health status and comorbidity.
They explained 46% of the variation between patients in
postoperative EQ-5D score.
The only variable associated with complication rate was
preoperative EQ-5D (area under ROC curve = 0.61) (ie, the
poorer a patient’s preoperative quality of life, the more likely
they reported a complication).
Appropriateness of surgery
If a change in VF-14 score of 5.5 is taken as an indication of a
worthwhile improvement in visual function (following Jaeschke
et al,22 based on the 85 patients reporting their problem to be ‘‘a
little better’’ in table 2), then a patient would need to have a
preoperative VF-14 score of less than 94.5 to be able to achieve
minimal benefit from surgery. On this basis, 30.3% of patients
would be deemed inappropriate. However, 94.3% of such
patients reported the results of their operation as ‘‘good,’’ ‘‘very
good’’ or ‘‘excellent’’ (table 3), and 95.7% reported their vision
as ‘‘a little better’’ or ‘‘much better’’ using a global retrospective
measure (table 4).
If the more stringent requirement of ‘‘much better’’ is
adopted (change in VF-14 score of 12.2), then 49.3% of patients
would be deemed inappropriate. Again, the majority of those
deemed inappropriate based on longitudinal data were, on the
basis of a single retrospective assessment, pleased with the
outcome (tables 3, 4).
DISCUSSION
Findings
This study confirmed that preoperative visual function,
measured using the VF-14, has increased among NHS patients
from a mean of 68.1 in 1994/199523 to 82.7 in 2006. The
proportion of patients with a score of 90 or more has risen from
18.1% to 45.0%. The mean VF-14 score is now similar to that
reported for privately funded patients in 2001 (83.2) and in
2005/2006 (84.4) (BUPA, personal communication). Based on
the VF-14, a high proportion of patients, 30–50%, can achieve
little or no improvement according to patients’ reports of the
impact on their visual function. Despite this, most patients
were satisfied with the result of their operation: 93.1% viewed
the outcome as good to excellent; 93.5% reported that their
problem was better.
Before considering explanations for such a discrepancy and
the issue of whether or not unnecessary surgery is taking place,
some limitations of the study need to be addressed.
Limitations
First, although we achieved a high recruitment rate (84% of
those invited) and high postoperative response rate (87%), the
exclusion of 17% of patients as ineligible because of difficulties
in completing the questionnaires probably excluded some of
those with the worst visual function and general health. This
would mean we may have underestimated slightly the mean
impact of surgery on visual function. Despite this, participants
were representative of those currently being treated in the NHS
as regards socio-demographic characteristics and general health
status. The proportion of patients undergoing second eye
surgery (34.0%) is similar to that reported elsewhere.
A second concern is the validity of our estimation of a
minimally important difference in VF-14 score. There is no
agreed method for determining what size of change on a scale
constitutes a ‘‘useful’’ benefit to a patient. We employed an
anchor-based method, using patients’ reports of ‘‘a little better’’
but as has been seen, patients reporting they were ‘‘about the
same’’ achieved a similar level change in VF-14 score (table 2).
This suggests that the use of 5.5 might underestimate a
Table 2 Association between ‘‘Overall, how are the
problems in the eye(s) that had surgery now compared to
before your operation?’’ and VF-14 change scores
Response n (%) VF-14 change score mean (SD)
Much better 605 (82.0) 12.2 (15.1)
A little better 85 (11.5) 5.5 (17.1)
About the same 23 (3.1) 7.3 (18.1)
A little worse 12 (1.6) –3.8 (15.1)
Much worse 13 (1.8) –19.0 (30.6)
Overall 738 (100.0) 10.4 (16.5)
Table 3 Association between ‘‘appropriateness’’ (determined by preop VF-14 score) and ‘‘How would you describe the results of your operation?’’
Result of operation ‘‘Appropriate’’ preop VF-14 ,94.5 ‘‘Inappropriate’’ preop VF-14 94.5+ ‘‘Appropriate’’ preop VF-14 ,87.8 ‘‘Inappropriate’’ preop VF-14 87.8+
Excellent 236 (45.7) 106 (46.1) 152 (41.3) 190 (50.3)
Very good 144 (27.9) 77 (33.5) 112 (30.4) 109 (28.8)
Good 96 (18.6) 34 (14.8) 74 (20.1) 56 (14.8)
Fair 25 (4.8) 8 (3.5) 18 (4.9) 15 (4.0)
Poor 15 (2.9) 5 (2.2) 12 (3.3) 8 (2.1)
Overall 516 (100.0) 230 (100.0) 368 (100.0) 378 (100.0)
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minimally important difference and, as a result, underestimate
the proportion of inappropriate operations. Conversely, the use
of an anchor-based method can be challenged. An alternative
approach is to derive a minimally important difference
statistically based on 0.2 of the standard deviation of the
preoperative VF-14. This gives a value of about 3.5, suggesting
that about 20% of cases may be inappropriate.
Third, the incidence of complications may be overestimated.
A patient may report discomfort from a wound as a ‘‘wound
problem’’ even though a surgeon may deem their experience as
‘‘normal and expected’’ rather than an abnormal, adverse
outcome. Also, if a patient experiences urinary symptoms
during the postoperative period, they may ascribe this to the
operation, whereas a clinician may perceive it as being
unrelated. For these reasons, the incidence of patient reported
‘‘complications’’ is likely to be higher than that reported by
clinicians.
And finally, ocular comorbidity (such as glaucoma) was not
taken into account, as it was felt accurate information could not
be obtained directly from patients. A small proportion of the
patients with good visual function may have suffered from
concomitant conditions that would justify cataract surgery.
Explanations
These limitations do little to explain the apparent inconsistency
we have found: 25% of patients report no change or a worsening of
visual function, yet only 6.9% report the result of surgery as only
fair or poor, and even fewer (3.4%) report no benefit or a
worsening of their eye problem. There are two likely explanations.
The first challenges the validity of the so-called ‘‘transition
questions’’ (ie, how are you now compared to before surgery?).
Consistent with studies of other surgical operations, most
patients report that they feel better and have no regrets about
having undergone surgery. Such views do not always reflect the
impact an operation has had on their functional health and
quality of life.24–26 This probably reflects patients’ reduced
anxiety having come through surgery and an understandable
need to justify to themselves that the decision to undergo
surgery had been the correct one. We have some evidence to
support this—the transition score correlates more with the
postoperative VF-14 (Spearman coefficient 0.37) than with the
preoperative score (0.09).
Second, the responsiveness and the validity of the VF-14 may
be inadequate. Studies demonstrating its satisfactory psycho-
metric properties were mostly conducted in the 1990s when
patients’ preoperative severity was greater than today: internal
consistency (a= 0.74–0.85; item-total correlations = 0.32–
0.61);8 21 intrarater reliability (ICC 0.79; 0.84);14 27 construct
validity;8 21 28 29 and responsiveness (effect size 0.87–1.49).27 28
However, by 2006, the severity of cataracts and the accom-
panying visual dysfunction had decreased considerably, throw-
ing into doubt the validity of the VF-14.
Its validity could have been compromised in two ways. First,
it has been suggested that the VF-14 does not reflect all the
concerns of cataract patients.30 A review of patients awaiting
surgery in Vancouver who had a score of 100 (no difficulties)
found that, on closer questioning, 72% reported they experi-
enced glare, double or blurry vision. These, and other effects,
have recently been described in the UK.31 Second, it could be
that patients are unaware of any visual dysfunction before
surgery because any deterioration has been so gradual. It is only
after surgery, when their vision is restored, that they become
aware of how much brighter and clearer the world can be. This
is an example of response shift. Such patients report no or little
dysfunction before surgery and the same afterwards, but still
report that the operation has had a beneficial impact.
Implications
There is a need for a new, improved instrument for assessing the
impact of cataract surgery on patients’ visual function and
quality of life. However, it is not clear how the challenge of
unperceived deficits can be tackled, a challenge that has been
recognised by others.32 If patients only become aware of visual
dysfunction after their function has been restored, how can the
extent of that improvement be measured? It clearly cannot be
done by comparing before and after assessments. The only way
would be by retrospective assessment, an approach with major
psychometric challenges. Yet until improvements in patients’
health-related quality of life can be measured, the cost–utility of
cataract surgery and an appropriate treatment threshold cannot
be determined. It would therefore be unwise for purchasers of
healthcare to use the preoperative VF-14 score as an indicator of
appropriateness. Our concerns about the validity of the VF-14
have recently been accepted by the English Department of
Health who have decided not to include cataract surgery as one
of the first elective procedures to be routinely assessed using
patient reported outcome measures.33 However, the warning
that unnecessary surgery might be occurring and the need for ‘‘a
reality check’’ remain.34
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Table 4 Association between ‘‘appropriateness’’ (determined by preop VF-14 score) and ‘‘Overall, how are the problems in the eye(s) that had surgery
now compared to before your operation?’’
Result of operation
‘‘Appropriate’’
Preop VF-14 ,94.5
‘‘Inappropriate’’
Preop VF-14 94.5+
‘‘Appropriate’’
Preop VF-14 ,87.8
‘‘Inappropriate’’
Preop VF-14 87.8+
Much better 417 (80.7) 194 (84.4) 287 (80.0) 323 (85.5)
A little worse 61 (11.8) 26 (11.3) 49 (13.3) 38 (10.1)
Same 18 (3.5) 5 (2.2) 15 (4.1) 7 (1.9)
A little worse 10 (1.9) 2 (0.9) 9 (2.5) 3 (0.8)
Much worse 11 (2.1) 3 (1.3) 7 (2.0) 7 (1.9)
Overall 517 (100.0) 230 (100.0) 367 (100.0) 378 (100.0)
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